Order Article Reprints

Stecanella LA, Bitencourt APR, Vaz GR, Quarta E, Silva Júnior JOC, Rossi A. Glycyrrhizic Acid and Its Hydrolyzed Metabolite 18β-Glycyrrhetinic Acid as Specific Ligands for Targeting Nanosystems in the Treatment of Liver Cancer. Pharmaceutics. 2021; 13(11):1792. https://doi.org/10.3390/pharmaceutics13111792

Stecanella, Luciano A., Antonio P. R. Bitencourt, Gustavo Richter Vaz, Eride Quarta, José O. C. Silva Júnior, and Alessandra Rossi. 2021. "Glycyrrhizic Acid and Its Hydrolyzed Metabolite 18β-Glycyrrhetinic Acid as Specific Ligands for Targeting Nanosystems in the Treatment of Liver Cancer" Pharmaceutics 13, no. 11: 1792. https://doi.org/10.3390/pharmaceutics13111792

Stecanella, L. A., Bitencourt, A. P. R., Vaz, G. R., Quarta, E., Silva Júnior, J. O. C., & Rossi, A. (2021). Glycyrrhizic Acid and Its Hydrolyzed Metabolite 18β-Glycyrrhetinic Acid as Specific Ligands for Targeting Nanosystems in the Treatment of Liver Cancer. Pharmaceutics, 13(11), 1792. https://doi.org/10.3390/pharmaceutics13111792